Reagents News and Research

RSS

Microchip Biotechnologies renamed as IntegenX

Microchip Biotechnologies, a maker of automated microscale biotech laboratory systems, today announced that it has changed its business name to IntegenX. The new name articulates the company's focus on integrating sample preparation and analysis technologies into complete products that address generic problems shared by life science and biotechnology research laboratories worldwide.

12 Mar 2010

PBI and TDI announce strategic licensing and collaborative research and development agreement

Pressure BioSciences, Inc. and Target Discovery, Inc.,, today announced a strategic product licensing, manufacturing, co-marketing, and collaborative research and development agreement. Under the terms of the Agreement, PBI has been licensed by TDI to manufacture and sell a highly innovative line of chemicals used in the preparation of tissues for scientific analysis.

11 Mar 2010

BioTime's fourth-quarter fiscal 2009 total quarterly revenue up 163%

BioTime, Inc. today reported financial results for the fourth quarter and fiscal year ended December 31, 2009 and provided an update on recent corporate developments.

10 Mar 2010

Fluidigm's Access Array System: New 5kb and 10kb long-range PCR protocols introduced

Fluidigm Corporation today announced the release of 5kb and 10kb long-range PCR protocols for its Access Array™ System. Researchers interested in targeted re-sequencing projects for large cohort studies can use these new protocols and the Fluidigm Access Array System to amplify up to 48 samples per array. Long-range PCR enables new applications on the Access Array System by allowing researchers to enrich significantly more sequence per sample.

8 Mar 2010

Thermo Fisher Scientific acquires Finnzymes

Thermo Fisher Scientific Inc., the world leader in serving science, has completed its previously announced acquisition of Finnzymes. The business is a well-recognized provider of integrated tools for high-performance polymerase chain reaction (PCR), including reagents, instruments, consumables and kits that make the PCR process faster and more accurate for applications including basic genomic research, genetic testing, forensics and food safety.

From Thermo Fisher Scientific Inc. 5 Mar 2010

China Medical Technologies reports revenues of US$25.2 million for third-quarter fiscal 2009

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced its unaudited financial results for the third fiscal quarter ended December 31, 2009 ("3Q FY2009"). The Company's 2009 fiscal year ends on March 31, 2010 ("FY2009").

3 Mar 2010

Greffex Group signs Strategic Alliance Framework Agreement with UPMC and ISMETT

The Greffex Group of regenerative medicine companies announces the signing of a Strategic Alliance Framework Agreement with UPMC and ISMETT, Italy.

2 Mar 2010

Sigma-Aldrich unveils new Sigma Life Science brand and website platform

Sigma-Aldrich® today unveiled its new Sigma® Life Science brand and website platform, designed to elevate the Company's current focus on biology and provide a single destination where researchers can access deep biological knowledge and market-leading products and technologies.

2 Mar 2010

Study results of new PCR technology that reports mutations associated with FXS announced

Asuragen, Inc. announced today the results of a collaborative study with scientists at the M.I.N.D. Institute at the University of California Davis evaluating a new PCR technology that reproducibly reports mutations associated with Fragile X syndrome (FXS).

2 Mar 2010

Life Technologies announces early stage results from SMS technology

Life Technologies Corporation today announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories and clinical settings worldwide.

2 Mar 2010

NIH Director announces seven new scientific programs scheduled to begin during fiscal year 2010

Programs to create a new center for the study of stem cells and to increase capacity to deal with global health issues were among seven scientific initiatives announced today by NIH Director Francis S. Collins, M.D., Ph.D. The seven research programs are supported through the NIH Common Fund, which encourages collaborative research programs across the NIH institutes and centers, or ICs, to accomplish work that no single IC could do alone.

26 Feb 2010

New England Biolabs adds NEBNext DNA Sample Prep Master Mix Set 3 for use with Life Technologies' SOLiD 3 System

New England Biolabs has expanded its line of reagents for sample preparation to include NEBNext™ DNA Sample Prep Master Mix Set 3, which has been validated for use with the SOLiD™ 3 System from Life Technologies. NEBNext reagents are a series of highly pure reagents that facilitate sample preparation for downstream applications, such as next generation sequencing. All reagents undergo stringent quality controls and functional validation, ensuring maximum yield, convenience and value.

From New England Biolabs 24 Feb 2010

PointCare Technologies donates rapid PointCare NOW tests to Haitian clinics

PointCare Technologies, pioneer inventor of a portable diagnostic system that enables effective HIV/AIDS monitoring for millions of people in remote areas of developing countries, has donated 4,000 (a month's supply) of its rapid PointCare NOW tests to Haitian clinics to ensure the resumption of critical care to HIV/AIDS patients.

24 Feb 2010

Winner of 2010 Anatrace Membrane Protein Award

Affymetrix, Inc. today announced that Professor Tom Rapoport of Harvard Medical School and Howard Hughes Medical Institute is the winner of the 2010 Anatrace Membrane Protein Award.

24 Feb 2010

New genetic analysis system for forensic DNA testing laboratories launched

Life Technologies Corporation today announced the launch of a new genetic analysis system designed to optimize data quality and deliver increased reliability, performance, quality assurance and ease-of-use specifically for forensic DNA testing laboratories.

24 Feb 2010

Gentel Biosciences launches integrated Proteomics Multi-System

Gentel Biosciences, a leader in proteomics discovery tools, today launched the Gentel Proteomics Multi-System™ providing “scan-to-analysis” functionality for multiplex immunoassays, lysate and antigen arrays as well as Western Blot, ELISA and tissue imaging, delivering multi-application value to researchers worldwide.

19 Feb 2010

Asuragen announces agreement to develop and manufacture RNA Control Kits for Affymetrix

Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to develop and manufacture RNA Control Kits for Affymetrix. The RNA Control Kit is intended for use with in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications that Asuragen has licensed and supplied to Affymetrix.

18 Feb 2010

Pacific Biosciences introduces partner program for SMRT DNA sequencing system

Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today announced the launch of a partner program designed to work with best-in-class organizations providing complementary solutions to its Single Molecule Real Time (SMRT™) DNA sequencing system. The program will help customers rapidly and easily adopt its third-generation DNA sequencing solution into their discovery programs.

17 Feb 2010

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

The new decade may herald an era of cell therapy -- treating human diseases by delivering highly specific beneficial cells. In the wake of an NIH decision late last year permitting federally funded researchers to use new lines of human embryonic stem cells, the door has opened more widely to stem cell research.

16 Feb 2010

Sony acquires iCyt Mission Technology

Sony Corporation (Sony) announced today that it has acquired iCyt Mission Technology, Inc. (iCyt), a leading producer of high-performance cell sorters used for stem cell and disease research, through its U.S. subsidiary, Sony Corporation of America (SCA).

10 Feb 2010

Reagents News and Research

Microchip Biotechnologies renamed as IntegenX

PBI and TDI announce strategic licensing and collaborative research and development agreement

BioTime's fourth-quarter fiscal 2009 total quarterly revenue up 163%

Fluidigm's Access Array System: New 5kb and 10kb long-range PCR protocols introduced

Thermo Fisher Scientific acquires Finnzymes

China Medical Technologies reports revenues of US$25.2 million for third-quarter fiscal 2009

Greffex Group signs Strategic Alliance Framework Agreement with UPMC and ISMETT

Sigma-Aldrich unveils new Sigma Life Science brand and website platform

Study results of new PCR technology that reports mutations associated with FXS announced

Life Technologies announces early stage results from SMS technology

NIH Director announces seven new scientific programs scheduled to begin during fiscal year 2010

New England Biolabs adds NEBNext DNA Sample Prep Master Mix Set 3 for use with Life Technologies' SOLiD 3 System

PointCare Technologies donates rapid PointCare NOW tests to Haitian clinics

Winner of 2010 Anatrace Membrane Protein Award

New genetic analysis system for forensic DNA testing laboratories launched

Gentel Biosciences launches integrated Proteomics Multi-System

Asuragen announces agreement to develop and manufacture RNA Control Kits for Affymetrix

Pacific Biosciences introduces partner program for SMRT DNA sequencing system

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

Sony acquires iCyt Mission Technology

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News